The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer

Journal of Surgical Oncology

Volumn 105, Issue 2, 2012, Pages 206-211

  Yin, Mingzhu ^a   Zhang, Haiyu ^a   Li, Huiyan ^a   Li, Xia ^b   Liu, Yunduo ^a   Chen, Xiuwei ^a   Lou, Ge ^a   Li, Kang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

cervical carcinoma; neoadjuvant chemotherapy; radical hysterectomy; survival

Indexed keywords

CISPLATIN; NEDAPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONSTIPATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEART ARRHYTHMIA; HUMAN; LEUKOPENIA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NAUSEA; NEPHROTOXICITY; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEINURIA; RADICAL HYSTERECTOMY; RETROSPECTIVE STUDY; SIDE EFFECT; SMALL CELL CARCINOMA; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR THROMBUS; UREA NITROGEN BLOOD LEVEL; UTERINE CERVIX CANCER; UTERUS CARCINOMA; VOMITING;

ADENOCARCINOMA; ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PACLITAXEL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84855393325     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22052     Document Type: Article

References (22)

1. Lai CH, Hsueh S, Chang TC, et al.: Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol 1997; 64: 456-462. (Pubitemid 27120436)
2. Choi CH, Kim TJ, Lee JW, et al.: Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2-IIB cervical carcinoma. Gynecol Oncol 2007; 104: 64-69. (Pubitemid 46054117)
3. Benedetti Panici P, Bellati F, Pastore M, et al.: An update in neoadjuvant chemotherapy in cervical cancer. Gynecol Oncol 2007; 107: S20-S22. (Pubitemid 47483879)
4. Green J, Kirwan J, Tierney J, et al.: Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 2005; 3: CD002225.
5. Rose PG, Bundy BN, Watkins EB, et al.: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144-1153. (Pubitemid 29177873)
6. Benedetti-Panici P, Greggi S, Scambia G, et al.: Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Eur J Cancer 1998; 34: 341-346. (Pubitemid 28183831)
7. Mingzhu Yin, Falin Z, Ge L, et al.: The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer. Int J Gynecol Cancer 2011; 21: 92-99.
8. Alberts DS, Fanta PT, Running KL, et al.: In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers. Cancer Chemother Pharmacol 1998; 39: 493-497.
9. Kawai Y, Taniuchi S, Okahara S,: Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation. Biol Pharm Bull 2005; 28: 1385-1388. (Pubitemid 41379685)
10. Koshiyama M, Kinezaki M, Uchida T, et al.: Chemosensitivity testing of a novel platinum analog, nedaplatin (254-S), in human gynecological carcinomas: A comparison with cisplatin. Anticancer Res 2005; 25: 4499-4502. (Pubitemid 41729503)
11. Ota K, Oguma T, Shimamura K,: Pharmacokinetics of platinum in cancer patients following intravenous infusion of cis-diammine(glycolato)platinum, 254-S. Anticancer Res 1994; 14: 1383-1387. (Pubitemid 24264193)
12. Cao W, Xu C, Lou G, et al.: A phase II study of paclitaxel and nedaplatin as first-line chemotherapy in patients with advanced esophageal cancer. Jpn J Clin Oncol 2009; 39: 582-587.
13. Kato T, Nishimura H, Yakushiji M, et al.: Phase II study of 254-S (cis-diammine glycolato platinum) for gynecological cancer. Gan To Kagaku Ryoho 1992; 19: 695-701.
14. Hirabayashi K, Okada E,: Combination chemotherapy with 254-S, ifosfamide, and peplomycin for advanced or recurrent cervical cancer. Cancer 1993; 71: 2769-2775. (Pubitemid 23120053)
15. Adachi S, Oqasawara T, Wakimoto E, et al.: Phase I/II study of intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical carcinoma. Cancer 2001; 91: 74-79. (Pubitemid 32052616)
16. Matsumura M, Takeshima N, Ota T, et al.: Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer-Irinotecan and platinum chemotherapy. Gynecol Oncol 2010; 119: 212-216.
17. Piver MS, Rutledge F, Smith JP,: Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974; 44: 265-272.
18. Peters WA, Liu PY, Barrett RJ, et al.: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18: 1606-1613. (Pubitemid 30220538)
19. Eisenhauer EA, Therasse P, Bogaerts J, et al.: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247.
20. World Health Organization: WHO handbook for reporting results of cancer treatment. Geneva: World Health Organization; 1979.
21. Duenas-Gonzalez A, Cetina L, Mariscal I, et al.: Modern management of locally advanced cervical carcinoma. Cancer Treat Rev 2003; 29: 389-399. (Pubitemid 37185105)
22. Osaka Y, Takagi Y, Hoshino S, et al.: Combination chemotherapy with docetaxel and nedaplatin for recurrent esophageal cancer in an outpatient setting. Dis Esophagus 2006; 19: 473-476. (Pubitemid 44644684)